Community Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$1.42K 391
2025
Q1
$1.42K Hold
50
﹤0.01% 372
2024
Q4
$2.08K Hold
50
﹤0.01% 375
2024
Q3
$3.34K Hold
50
﹤0.01% 370
2024
Q2
$5.94K Hold
50
﹤0.01% 371
2024
Q1
$5.33K Hold
50
﹤0.01% 377
2023
Q4
$4.97K Hold
50
﹤0.01% 382
2023
Q3
$5.16K Hold
50
﹤0.01% 381
2023
Q2
$6.08K Hold
50
﹤0.01% 392
2023
Q1
$7.68K Buy
+50
New +$8.25K ﹤0.01% 396
2022
Q4
Sell
-10
Closed -$1K 609
2022
Q3
$1K Buy
+10
New +$1.52K ﹤0.01% 590
2022
Q1
Sell
-125
Closed -$32K 447
2021
Q4
$32K Sell
125
-75
-38% -$21.9K ﹤0.01% 323
2021
Q3
$77K Hold
200
0.01% 293
2021
Q2
$47K Hold
200
0.01% 319
2021
Q1
$26K Hold
200
﹤0.01% 342
2020
Q4
$21K Hold
200
﹤0.01% 348
2020
Q3
$14K Buy
+200
New +$13.9K ﹤0.01% 367

Other funds holding MRNA

Community Bank's MRNA Position: Q2 2025 in Review

Community Bank sold out of Moderna (MRNA) in Q2 2025, closing a stake of 50 shares — an estimated $1.42K sold.

Community Bank first reported a position in MRNA in Q3 2020 and held it in 16 quarters. The position peaked at $77K in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Community Bank reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Community Bank sold 50 Moderna shares in Q2 2025, an estimated $1.42K.
  • Community Bank first reported a position in Moderna in Q3 2020 and held it in 16 quarters.
  • Community Bank's Moderna position peaked at $77K in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Community Bank's 13F filing for Q2 2025, filed 25 Jul 2025.